Paper7744265
AZT toxicity and AIDS prophylaxis: is AZT beneficial for HIV+ asymptomatic persons with 500 or more T4 cells per cubic millimeter?
Zaretsky MD. Genetica, 1995. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. AZT toxicity and AIDS prophylaxis: is AZT beneficial for HIV+ asymptomatic persons with 500 or more T4 cells per cubic millimeter? Papers, record 7744265. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7744265
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- AZT toxicity and AIDS prophylaxis: is AZT beneficial for HIV+ asymptomatic persons with 500 or more T4 cells per cubic millimeter?
- PubMed
- Publication types
- Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acquired Immunodeficiency Syndrome | Major topic |
| HIV Seropositivity | Major topic |
| Zidovudine | Major topic |
| CD4-Positive T-Lymphocytes | |
| Cohort Studies | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Immune System | |
| Lymphocyte Count | |
| Male |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| N0I-AI-82515 | NIAID NIH HHS | United States | N01AI082515 | PubMed and NIH |
Source NIH RePORTER
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1969115 | Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. | N Engl J Med | 1990 | https://conductscience.org/library/papers/1969115 | PubMed |
| 2 | 3299089 | The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. | N Engl J Med | 1987 | https://conductscience.org/library/papers/3299089 | PubMed |
| 3 | 3044087 | Results of continued monitoring of participants in the placebo-controlled trial of zidovudine for serious human immunodeficiency virus infection. | Am J Med | 1988 | https://conductscience.org/library/papers/3044087 | PubMed |
| 4 | 1611806 | Clinical pharmacokinetics of 3'-azido-3'-deoxythymidine (zidovudine) and catabolites with formation of a toxic catabolite, 3'-amino-3'-deoxythymidine. | Clin Pharmacol Ther | 1992 | https://conductscience.org/library/papers/1611806 | PubMed |
| 5 | 8100612 | Zidovudine now or later? | N Engl J Med | 1993 | https://conductscience.org/library/papers/8100612 | PubMed |
| 6 | 2847772 | Inhibition of bone marrow myelopoiesis and erythropoiesis in vitro by anti-retroviral nucleoside derivatives. | Br J Haematol | 1988 | https://conductscience.org/library/papers/2847772 | PubMed |
| 7 | 2903403 | Zidovudine and bone marrow. | Lancet | 1988 | https://conductscience.org/library/papers/2903403 | PubMed |
| 8 | 8096582 | Preliminary analysis of the Concorde trial. Concorde Coordinating Committee. | Lancet | 1993 | https://conductscience.org/library/papers/8096582 | PubMed |
| 9 | 2554533 | A comparison of three nucleoside analogs with anti-retroviral activity on immune and hematopoietic functions in mice: in vitro toxicity to precursor cells and microstromal environment. | Toxicol Appl Pharmacol | 1989 | https://conductscience.org/library/papers/2554533 | PubMed |
| 10 | 8425021 | Nucleoside analogs: similarities and differences. | Clin Infect Dis | 1993 | https://conductscience.org/library/papers/8425021 | PubMed |
| 11 | 8100273 | A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-seropositive homosexual men. | J Acquir Immune Defic Syndr (1988) | 1993 | https://conductscience.org/library/papers/8100273 | PubMed |
| 12 | 3540327 | Sexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men's Health Study. | JAMA | 1987 | https://conductscience.org/library/papers/3540327 | PubMed |
| 13 | 8096373 | CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. | Ann Intern Med | 1993 | https://conductscience.org/library/papers/8096373 | PubMed |
| 14 | 3497175 | Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome. | J Clin Invest | 1987 | https://conductscience.org/library/papers/3497175 | PubMed |
| 15 | 3299090 | The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. | N Engl J Med | 1987 | https://conductscience.org/library/papers/3299090 | PubMed |
| 16 | 6465173 | Hematologic abnormalities in the acquired immune deficiency syndrome. | Am J Med | 1984 | https://conductscience.org/library/papers/6465173 | PubMed |
| 17 | 7904317 | Coinfection with human T-cell lymphotropic virus type I and HIV in Brazil. Impact on markers of HIV disease progression. | JAMA | 1994 | https://conductscience.org/library/papers/7904317 | PubMed |
| 18 | 3477107 | Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS). | Ann Intern Med | 1987 | https://conductscience.org/library/papers/3477107 | PubMed |
| 19 | 2991932 | High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states. | Proc Natl Acad Sci U S A | 1985 | https://conductscience.org/library/papers/2991932 | PubMed |
| 20 | 3010072 | Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections. | MMWR Morb Mortal Wkly Rep | 1986 | https://conductscience.org/library/papers/3010072 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 12183239 | Immunomodulatory effect of zidovudine (ZDV) on cytotoxic T lymphocytes previously exposed to ZDV. | Antimicrob Agents Chemother | 2002 | https://conductscience.org/library/papers/12183239 | PubMed |
| 10389983 | Swainsonine protects both murine and human haematopoietic systems from chemotherapeutic toxicity. | Br J Cancer | 1999 | https://conductscience.org/library/papers/10389983 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7744265
GET https://conductscience.org/api/papers/v1/7744265/references?page=2